Cormedix (CRMD)

Cormedix (CRMD) Stock Price & Analysis


CRMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.71 - $6.09
Previous Close$3.7
Average Volume (3M)569.65K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$52.49M
Total Debt (Recent Filing)$736.86K
Price to Earnings (P/E)-4.3
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding54,805,376
10 Day Avg. Volume535,323
30 Day Avg. Volume569,654
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)4.10
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio8594.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside287.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Cormedix’s price range in the past 12 months?
Cormedix lowest stock price was $2.71 and its highest was $6.09 in the past 12 months.
    What is Cormedix’s market cap?
    Currently, no data Available
    When is Cormedix’s upcoming earnings report date?
    Cormedix’s upcoming earnings report date is Nov 09, 2023 which is in 40 days.
      How were Cormedix’s earnings last quarter?
      Cormedix released its earnings results on Aug 08, 2023. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.239 by -$0.011.
        Is Cormedix overvalued?
        According to Wall Street analysts Cormedix’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cormedix pay dividends?
          Cormedix does not currently pay dividends.
          What is Cormedix’s EPS estimate?
          Cormedix’s EPS estimate is -$0.24.
            How many shares outstanding does Cormedix have?
            Cormedix has 54,812,042 shares outstanding.
              What happened to Cormedix’s price movement after its last earnings report?
              Cormedix reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.239. Following the earnings report the stock price went up 7.805%.
                Which hedge fund is a major shareholder of Cormedix?
                Among the largest hedge funds holding Cormedix’s share is Elliott Investment Management LP. It holds Cormedix’s shares valued at 6M.


                  Cormedix Stock Smart Score

                  The Cormedix stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.


                  Top 5 ETFs holding CRMD

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Dimensional US Sustainability Core 1 ETF
                  Up to five ETFs with an Outperform Smart Score that hold CRMD. The ETFs are listed according to market value of CRMD within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Agile Therapeutics
                  Xeris Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis